Page contentsKey factsDecisionKey facts Active Substance diclofenacthiocolchicoside Therapeutic area Pain Decision number P/0022/2023 PIP number EMEA-003339-PIP01-22 Pharmaceutical form(s) Orodispersible tabletConcentrate for solution for injection Condition(s) / indication(s) Treatment of pain Route(s) of administration Oral useIntramuscular use Contact for public enquiries Verisfield Single Member S.A.Email: pharmacovigilance@verisfield.grtel: +30 2107475196 Decision type W: decision granting a waiver in all age groups for all conditions or indications Decision date 31/01/2023DecisionP/0022/2023 ; EMA decision of 31 January 2023 on the granting of a product specific waiver for diclofenac / thiocolchicoside (EMEA-003339-PIP01-22)Reference Number: EMA/30270/2023 English (EN) (196.04 KB - PDF)First published: 11/01/2024ViewShare this page